Evaluation of vinblastine administered by 5-day continuous infusion in women with advanced breast cancer.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007263:Infusions, Parenteral; D008875:Middle Aged; D014747:Vinblastine / Q000008:administration & dosage* / Q000009:adverse effects
D014747:Vinblastine